Crossmark

A single center study that evaluates the preclinical use of a newly developed software and moving bed system to facilitate the spontaneous excretion of residual fragments after primary stone treatment (RIRS or PCNL)

Crossref DOI link: https://doi.org/10.1007/s00345-021-03863-7

Published Online: 2021-10-23

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Tao

Song, Rijin

Meng, Xianghu

Wei, Hanping

Jiang, Xinying

Yuan, Xiaoliang

Liu, Xiaowu

Jiao, Zhimin

Liu, Jun

Shi, Honglei
Funding

Funding for this research was provided by:

the clinical medical science and technology development fund of jiangsu university (JLY2021026)

the eighth batch of science and technology plan projects of changzhou in 2019 (CE20195002)

the key youth medical talents project in jiangsu province (QNRC2016312)

the high level talents project of changzhou (2016CZBJ056)
License Information

Text and Data Mining valid from 2021-10-23

Version of Record valid from 2021-10-23
More Information

Article History

Received: 23 July 2021

Accepted: 7 October 2021

First Online: 23 October 2021

Declarations

:

: None of the authors have any conflicts of interest or financial ties to disclose.

: This study was approved by our local ethics committee and was, therefore, performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments<b>.</b> All participants gave their informed consent to provide stone material and CTU data prior to their inclusion in the study. The study was approved by the Ethics Committee of Wujin Hospital affiliated with Jiangsu University.

Document is current

Any future updates will be listed below